Skip to main content
ROQUEFORT THERAPEUTICS PLC logo

ROQUEFORT THERAPEUTICS PLC — Investor Relations & Filings

Ticker · ROQ ISIN · GB00BMDQ2T15 LEI · 254900P4SISIWOR9RH34 IL Professional, scientific and technical activities
Open in API
Filings indexed 182 across all filing types
Latest filing 2021-12-21 Major Shareholding Noti…
Country GB United Kingdom
Listing IL ROQ

About ROQUEFORT THERAPEUTICS PLC

https://www.roquefortplc.com/

Roquefort Therapeutics PLC is a biotechnology company focused on developing next-generation, first-in-class medicines for hard-to-treat cancers. The company operates within the high-growth immuno-oncology market. Its portfolio consists of five novel, patent-protected, pre-clinical anti-cancer programs. These programs are designed to target cancers that have become resistant to existing therapies. Roquefort Therapeutics utilizes a distributed R&D model, combining its in-house expertise and laboratory facilities with a network of partnerships with leading academic cancer research centers to advance its development strategy.

Recent filings

Filing Released Lang Actions
Acquisition Completion, Admission & Voting Rights
Major Shareholding Notification Classification · 99% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content details a significant corporate action: the completion of an acquisition, the admission of enlarged share capital to the Official List, a successful placing (fundraising), and a proposed name change. These are typical announcements made via regulatory news services. Since it is a specific announcement of corporate events (acquisition completion, admission, fundraising details) rather than a general report or a notice about a report, it fits best under the general Regulatory Filings category (RNS), as it is a direct regulatory news service release.
2021-12-21 English
Roquefort Investments Plc - Single prospectus
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus prepared under the UK Prospectus Regulation and approved by the Financial Conduct Authority (FCA). It relates to a proposed acquisition (reverse takeover) and a placing of new ordinary shares, including admission to the London Stock Exchange's main market. The document includes detailed sections such as risk factors, financial review, pro forma statements, and other comprehensive information typical of a prospectus for capital raising and acquisition. This is not a simple announcement or a brief summary but a full prospectus document. The content and context clearly indicate this is a Capital/Financing Update filing, as it deals with share placing, admission, and acquisition financing activities.
2021-12-20 English
Prospectus dated 16 December 2021
Capital/Financing Update Classification · 95% confidence The document explicitly identifies itself as a "prospectus" for the purposes of Article 3 of the UK version of Regulation (EU) 2017/1129, approved by the FCA. It details a proposed acquisition (Reverse Takeover), a Placing of shares, and the intended Admission of shares to the London Stock Exchange. A prospectus is a mandatory disclosure document required when offering securities to the public or seeking admission to trading on a regulated market. While the definitions provided do not have a specific code for 'Prospectus', the content—offering shares, detailing risks, financial information (Table of Contents includes Historical Financial Information and Pro Forma Statement), and regulatory compliance (FCA approval)—is characteristic of a document used for a public offering or listing. Given the options, this document is fundamentally related to raising capital and listing shares, which aligns most closely with 'Capital/Financing Update' (CAP) or potentially a very detailed 'Investor Presentation' (IP) or a filing that precedes a major corporate action. However, a Prospectus is a unique, highly regulated document. Since the document is extremely long (498,752 chars) and contains the full substance of the offering, it is not a simple 'Report Publication Announcement' (RPA). The core purpose is the offering and admission of shares following an acquisition, which is a significant capital/financing event. In many regulatory contexts, a prospectus related to a listing/offering is often categorized under financing activities. Given the comprehensive nature and the focus on the Placing and Admission, 'CAP' (Capital/Financing Update) is the most appropriate fit among the provided codes, as it details the terms of the share issue and admission.
2021-12-16 English
Publication of Prospectus
Regulatory Filings Classification · 98% confidence The document is an official announcement released via RNS (Regulatory News Service) on December 16, 2021. The primary subject is the "Publication of Prospectus" related to a proposed acquisition (Lyramid Pty Limited) and a conditional placing to raise £3 million. This announcement details the terms of a significant corporate action (acquisition and fundraising) and confirms the publication of the required legal document (Prospectus). Since the document itself is an announcement about the publication of a Prospectus and details capital structure changes (Placing Shares, Consideration Shares), it relates to financing activities and the release of a formal document. Given the content focuses heavily on the issuance of shares for fundraising (£3 million placing) and an acquisition, it strongly aligns with capital/financing activities (CAP). However, the document explicitly announces the *publication* of the Prospectus and is distributed via RNS. A Prospectus publication related to fundraising and acquisition is a key event. Since the document is an announcement about a major corporate action involving fundraising and the release of a formal document (Prospectus), and it is distributed via RNS, it fits best under Capital/Financing Update (CAP) as the core event is the fundraising/acquisition structure, or potentially RPA if it were just announcing the availability of the Prospectus without the detailed financial context. Because it details the cash consideration, placing proceeds, and share allotments, CAP is the most specific fit for the underlying corporate event. If the document were merely a cover letter stating the Prospectus is attached, RPA would be better. Here, the substance is the financing/acquisition details.
2021-12-16 English
Resolutions passed at general meeting
AGM Information Classification · 98% confidence The document is titled "PRINT OF ORDINARY AND SPECIAL RESOLUTIONS" passed at a general meeting of Roquefort Investments PLC on December 13, 2021. It details specific resolutions concerning the authorization to allot shares (Ordinary Resolution 1) and the empowerment of directors regarding equity securities (Special Resolution 2), along with other procedural resolutions. This content directly relates to decisions made and approved during a shareholder meeting, specifically detailing the outcomes of voting on key corporate actions. This aligns perfectly with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). While it contains resolutions, it is the record of what was passed at the meeting itself, making AGM-R the most appropriate classification over DVA (which is strictly the *results* of the vote, whereas this is the *substance* of the resolutions passed at the meeting).
2021-12-14 English
Results of General Meeting
AGM Information Classification · 99% confidence The document explicitly states it is announcing the "Results of General Meeting". It details that all proposed resolutions were duly passed and provides a table showing the poll results (For/Against/Abstain) for each resolution. This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). Although it is distributed via RNS, the specific content is about voting results, making DVA the most precise classification.
2021-12-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.